AU680731B2 - New pharmaceutical dosage form for transdermal administration - Google Patents

New pharmaceutical dosage form for transdermal administration Download PDF

Info

Publication number
AU680731B2
AU680731B2 AU17675/95A AU1767595A AU680731B2 AU 680731 B2 AU680731 B2 AU 680731B2 AU 17675/95 A AU17675/95 A AU 17675/95A AU 1767595 A AU1767595 A AU 1767595A AU 680731 B2 AU680731 B2 AU 680731B2
Authority
AU
Australia
Prior art keywords
weight
composition
vitamin
skin
active principle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU17675/95A
Other languages
English (en)
Other versions
AU1767595A (en
Inventor
Philippe Laurent
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon France SAS
Original Assignee
Laboratoire L Lafon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire L Lafon SA filed Critical Laboratoire L Lafon SA
Publication of AU1767595A publication Critical patent/AU1767595A/en
Application granted granted Critical
Publication of AU680731B2 publication Critical patent/AU680731B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU17675/95A 1994-04-29 1995-04-28 New pharmaceutical dosage form for transdermal administration Ceased AU680731B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9405272A FR2719220A1 (fr) 1994-04-29 1994-04-29 Nouvelle forme galénique pour l'administration transdermique.
FR9405272 1994-04-29

Publications (2)

Publication Number Publication Date
AU1767595A AU1767595A (en) 1995-11-16
AU680731B2 true AU680731B2 (en) 1997-08-07

Family

ID=9462709

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17675/95A Ceased AU680731B2 (en) 1994-04-29 1995-04-28 New pharmaceutical dosage form for transdermal administration

Country Status (15)

Country Link
EP (1) EP0679392B1 (enExample)
JP (1) JP2740465B2 (enExample)
KR (1) KR100233770B1 (enExample)
AT (1) ATE210430T1 (enExample)
AU (1) AU680731B2 (enExample)
CA (1) CA2148112C (enExample)
DE (1) DE69524470T2 (enExample)
DK (1) DK0679392T3 (enExample)
ES (1) ES2169746T3 (enExample)
FR (1) FR2719220A1 (enExample)
HU (1) HU221599B (enExample)
NZ (1) NZ272014A (enExample)
PT (1) PT679392E (enExample)
TW (1) TW448050B (enExample)
ZA (1) ZA953392B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2740038B1 (fr) * 1995-10-20 1998-01-02 Lafon Labor Composition pour l'administration transdermique
DE69717847T2 (de) * 1996-10-24 2003-09-18 The Procter & Gamble Company, Cincinnati Hautgeruchsreduzierungskompositionen
US5968919A (en) * 1997-10-16 1999-10-19 Macrochem Corporation Hormone replacement therapy drug formulations for topical application to the skin
DE19830732B4 (de) * 1998-07-09 2008-11-13 Lts Lohmann Therapie-Systeme Ag Zusammensetzung, enthaltend mindestens einen die Blutfettwerte beeinflussenden Wirkstoff und seine Verwendung
US6512072B1 (en) 2000-06-12 2003-01-28 Dow Corning Corporation Fast cure film forming formulation
FR2827764B1 (fr) * 2001-07-27 2005-08-19 Oreal Composition, notamment cosmetique, renfermant un steroide et un glycol
ATE388697T1 (de) * 2003-11-21 2008-03-15 Galderma Res & Dev Sprühbare zusammensetzung zur verabreichung von vitamin d derivaten
FR2867682B1 (fr) * 2004-03-22 2009-06-05 Galderma Res & Dev Composition pharmaceutique anhydre associant un agent silicone et un principe actif solubilise.
AU2005253735A1 (en) * 2004-06-17 2005-12-29 Galderma S.A. Composition for the treatment of psoriasis comprising a silicone agent, a corticosteroid and vitamin D or a derivative thereof
FR2871695B1 (fr) 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un agent silicone et deux principes actifs solubilises
FR2887150B1 (fr) * 2005-06-17 2007-08-03 Galderma Res & Dev Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise
FR2909284B1 (fr) * 2006-11-30 2012-09-21 Galderma Sa Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP2008651A1 (en) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
PT2686017T (pt) 2011-03-14 2019-10-24 Drug Delivery Solutions Ltd Uma composição oftálmica.
US20130323332A1 (en) * 2012-05-31 2013-12-05 Sherry May Raymond-Coblantz Hand and body moisturizing serum
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3836647A (en) * 1970-10-22 1974-09-17 Dow Corning Wash-resistant skin preparation
US5232935A (en) * 1991-07-03 1993-08-03 Dow Corning France S.A. Composition for enhancing drug permeation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2140491A1 (de) * 1971-08-12 1973-02-22 Pawlowa Komposition zur bakteriziden bearbeitung einzelner bereiche der menschlichen haut und zur behandlung von hauterkrankungen
US4584192A (en) * 1984-06-04 1986-04-22 Minnesota Mining & Manufacturing Company Film-forming composition containing an antimicrobial agent and methods of use
EP0289900A1 (en) * 1987-04-30 1988-11-09 Abbott Laboratories Topical antibacterial compositions
JPH02145512A (ja) * 1988-11-26 1990-06-05 Shin Etsu Chem Co Ltd 被膜形成型外用剤
IN172390B (enExample) * 1989-07-18 1993-07-10 Ethicon Inc
DE69007886T2 (de) * 1989-07-21 1994-11-17 Izhak Blank Östradiol enthaltende Mittel und Verfahren zur topischen Anwendung.
TW247878B (enExample) * 1991-07-02 1995-05-21 Takeda Pharm Industry Co Ltd
EP0560014A1 (en) * 1992-03-12 1993-09-15 Atrix Laboratories, Inc. Biodegradable film dressing and method for its formation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3836647A (en) * 1970-10-22 1974-09-17 Dow Corning Wash-resistant skin preparation
US5232935A (en) * 1991-07-03 1993-08-03 Dow Corning France S.A. Composition for enhancing drug permeation

Also Published As

Publication number Publication date
TW448050B (en) 2001-08-01
EP0679392A1 (fr) 1995-11-02
JPH0859456A (ja) 1996-03-05
ATE210430T1 (de) 2001-12-15
DE69524470T2 (de) 2002-05-23
CA2148112C (en) 2001-01-30
KR950028767A (ko) 1995-11-22
NZ272014A (en) 1997-05-26
FR2719220B1 (enExample) 1997-02-14
AU1767595A (en) 1995-11-16
EP0679392B1 (fr) 2001-12-12
HU9501245D0 (en) 1995-06-28
HU221599B (hu) 2002-11-28
JP2740465B2 (ja) 1998-04-15
ES2169746T3 (es) 2002-07-16
CA2148112A1 (en) 1995-10-30
PT679392E (pt) 2002-05-31
ZA953392B (en) 1996-10-28
DK0679392T3 (da) 2002-04-08
HK1008658A1 (en) 1999-05-14
DE69524470D1 (de) 2002-01-24
FR2719220A1 (fr) 1995-11-03
HUT75251A (en) 1997-05-28
KR100233770B1 (ko) 1999-12-01

Similar Documents

Publication Publication Date Title
US6538039B2 (en) Pharmaceutical dosage form for transdermal administration
AU680731B2 (en) New pharmaceutical dosage form for transdermal administration
KR960006859B1 (ko) 티로시나제 저해 활성을 갖는 약물의 안정성을 개선하는 방법
KR100447034B1 (ko) 경피투여를위한조성물
HK1245143A1 (zh) 在癌症化疗和放疗时保护细胞的局部血管收缩剂制品和方法
EP0431519A1 (en) System for transdermal albuterol administration
CN109310647A (zh) 具有增强渗透的药物组合物
CA2000837A1 (en) Gel bases for pharmaceutical compositions
FR2698787A1 (fr) Patches médicinaux pour administration par voie percutanée.
EP0760238A1 (en) Percutaneously administrable preparation for treating urination disorder
JPH10508856A (ja) スキンケア組成物及びその適用方法
JP2012092130A (ja) 経皮ホルモン送達システム：組成物および方法
US20090042950A1 (en) Transdermal topical composition and its uses
JPH08508266A (ja) 皮膚へのエストラジオール放出用活性物質パッチ
EP0582502B1 (fr) Préparation pharmaceutique transdermique à base d'alfuzosine
CN113613637B (zh) 含有阿戈美拉汀的经皮治疗系统
EP0535237A1 (en) Composition for relieving skin irritation and external preparation for percutaneous adminstration containing the same
HU205722B (en) Method for producing self-adhesive device serving for percutaneous feeding agent
JP3657435B2 (ja) 経皮吸収用組成物
CA2028256A1 (en) Multiple layer transdermal drug administration system
HK1008658B (en) Pharmaceutical form for transdermal administration
TW397688B (en) Compositions effective in enhancing the qualities of skin and comprising macrocyclic ester, diester, ketone or lactone as an active ingredient
WO2025226898A1 (en) Compositions and methods for the treatment of epidermolysis bullosa
WO2014151587A2 (en) Amphiphilic resin linear copolymers for pharmaceutical drug delivery applications
KR20010008665A (ko) 라우릴디에탄올아미드를 함유하는 옥시부티닌의 투과증진제 조성물